Rotarix™ Significantly Reduced Severe Rotavirus Gastroenteritis In African Babies During Their First Year Of Life

The New England Journal of (NEJM) published the first study demonstrating that Rotarix™, GlaxoSmithKline’s rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2% of these infants. The study also showed that Rotarix…


Read more

Related posts

Leave a Reply